Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10940978 | 0.80 | GAA (0.46) | GAAHSD17B10ALDH1A1TDP1LMNA | |
| SCHEMBL9704412 | 0.78 | GAA (0.39) | GAAHSD17B10ALDH1A1TDP1LMNA | |
| SCHEMBL7590859 | 0.76 | GAA (0.38) | GAAHSD17B10ALDH1A1LMNA | |
| SCHEMBL29135299 | 0.73 | DGAT1 (0.40) | GAAHSD17B10ALDH1A1LMNA | |
| SCHEMBL25573784 | 0.73 | GAA (0.40) | GAAHSD17B10ALDH1A1LMNA | |
| SCHEMBL128895 | 0.70 | GAA (0.41) | GAAHSD17B10ALDH1A1TDP1LMNA | |
| SCHEMBL10942459 | 0.70 | FAAH (0.41) | HSD17B10ALDH1A1 | |
| SCHEMBL144976 | 0.69 | GAA (0.44) | GAAHSD17B10ALDH1A1TDP1LMNA | |
| SCHEMBL812117 | 0.69 | GAA (0.44) | GAAHSD17B10ALDH1A1TDP1LMNA | |
| SCHEMBL21939904 | 0.69 | ALDH1A1 (0.43) | GAAHSD17B10ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060004213-A1 | 1-Acetoxy-3-(substituted phenyl)propene compounds | UBE INDUSTRIES, LTD., A CORPORATION OF JAPAN (JP) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004213-A1 | 1-Acetoxy-3-(substituted phenyl)propene compounds | AKR1C3, P4HA1, AKR1C1 | GAA 4743/4885HSD17B10 141/4885ALDH1A1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.